MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas

Gabriella Aquino, Laura Marra, Monica Cantile, Annarosaria De Chiara, Giuseppina Liguori, Maria Pia Curcio, Rocco Sabatino, Giuseppe Pannone, Antonio Pinto, Gerardo Botti, Renato Franco

Research output: Contribution to journalArticle

Abstract

Myc oncogenetic deregulation is abundantly described in several solid human cancer and lymphomas. Particularly, Burkitt's lymphoma belongs to the family of B Non Hodgkin aggressive lymphomas. Although it is morphologically characterized, immunophenotypic and cytogenetic diagnosis remains complex. In 2008, the WHO has introduced a new diagnostic class of aggressive B-cell lymphomas with features intermediate between BL and DLBCL. This diagnostic class represents a temporary container of aggressive B-cell lymphomas, not completely belonging to the BL and DLBCL categories. The importance of establishing a correct diagnosis would allow a better prognostic classification and a better therapeutic approach. In this review, we summarize the main diagnostic approaches necessary for appropriate diagnoses and we emphasize the importance of cytogenetic analysis of the oncogene Myc in the histopathological diagnosis and the prognostic/predictive stratification. In this contest, Myc represents the more involved gene in the development of these lymphomas. Therefore, we analyze the genetic aberrations causing its over-expression and the concomitant deregulation of molecular pathways related to it. We also propose a FISH approach useful in the diagnosis of these lymphomas.

Original languageEnglish
Article number37
JournalInfectious Agents and Cancer
Volume8
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Chromosome Aberrations
Lymphoma
Differential Diagnosis
B-Cell Lymphoma
myc Genes
Burkitt Lymphoma
Cytogenetic Analysis
Cytogenetics
Non-Hodgkin's Lymphoma
Genes
Neoplasms
Therapeutics

Keywords

  • Aggressive non-Hodgkin B-cell lymphoma
  • B-cell lymphoma unclassifiable
  • Burkitt Lymphoma
  • Diffuse large B cell lymphoma
  • FISH
  • MYC

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas. / Aquino, Gabriella; Marra, Laura; Cantile, Monica; De Chiara, Annarosaria; Liguori, Giuseppina; Curcio, Maria Pia; Sabatino, Rocco; Pannone, Giuseppe; Pinto, Antonio; Botti, Gerardo; Franco, Renato.

In: Infectious Agents and Cancer, Vol. 8, No. 1, 37, 2013.

Research output: Contribution to journalArticle

@article{6e6f718d400641b78aeb94f9e96c1716,
title = "MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas",
abstract = "Myc oncogenetic deregulation is abundantly described in several solid human cancer and lymphomas. Particularly, Burkitt's lymphoma belongs to the family of B Non Hodgkin aggressive lymphomas. Although it is morphologically characterized, immunophenotypic and cytogenetic diagnosis remains complex. In 2008, the WHO has introduced a new diagnostic class of aggressive B-cell lymphomas with features intermediate between BL and DLBCL. This diagnostic class represents a temporary container of aggressive B-cell lymphomas, not completely belonging to the BL and DLBCL categories. The importance of establishing a correct diagnosis would allow a better prognostic classification and a better therapeutic approach. In this review, we summarize the main diagnostic approaches necessary for appropriate diagnoses and we emphasize the importance of cytogenetic analysis of the oncogene Myc in the histopathological diagnosis and the prognostic/predictive stratification. In this contest, Myc represents the more involved gene in the development of these lymphomas. Therefore, we analyze the genetic aberrations causing its over-expression and the concomitant deregulation of molecular pathways related to it. We also propose a FISH approach useful in the diagnosis of these lymphomas.",
keywords = "Aggressive non-Hodgkin B-cell lymphoma, B-cell lymphoma unclassifiable, Burkitt Lymphoma, Diffuse large B cell lymphoma, FISH, MYC",
author = "Gabriella Aquino and Laura Marra and Monica Cantile and {De Chiara}, Annarosaria and Giuseppina Liguori and Curcio, {Maria Pia} and Rocco Sabatino and Giuseppe Pannone and Antonio Pinto and Gerardo Botti and Renato Franco",
year = "2013",
doi = "10.1186/1750-9378-8-37",
language = "English",
volume = "8",
journal = "Infectious Agents and Cancer",
issn = "1750-9378",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas

AU - Aquino, Gabriella

AU - Marra, Laura

AU - Cantile, Monica

AU - De Chiara, Annarosaria

AU - Liguori, Giuseppina

AU - Curcio, Maria Pia

AU - Sabatino, Rocco

AU - Pannone, Giuseppe

AU - Pinto, Antonio

AU - Botti, Gerardo

AU - Franco, Renato

PY - 2013

Y1 - 2013

N2 - Myc oncogenetic deregulation is abundantly described in several solid human cancer and lymphomas. Particularly, Burkitt's lymphoma belongs to the family of B Non Hodgkin aggressive lymphomas. Although it is morphologically characterized, immunophenotypic and cytogenetic diagnosis remains complex. In 2008, the WHO has introduced a new diagnostic class of aggressive B-cell lymphomas with features intermediate between BL and DLBCL. This diagnostic class represents a temporary container of aggressive B-cell lymphomas, not completely belonging to the BL and DLBCL categories. The importance of establishing a correct diagnosis would allow a better prognostic classification and a better therapeutic approach. In this review, we summarize the main diagnostic approaches necessary for appropriate diagnoses and we emphasize the importance of cytogenetic analysis of the oncogene Myc in the histopathological diagnosis and the prognostic/predictive stratification. In this contest, Myc represents the more involved gene in the development of these lymphomas. Therefore, we analyze the genetic aberrations causing its over-expression and the concomitant deregulation of molecular pathways related to it. We also propose a FISH approach useful in the diagnosis of these lymphomas.

AB - Myc oncogenetic deregulation is abundantly described in several solid human cancer and lymphomas. Particularly, Burkitt's lymphoma belongs to the family of B Non Hodgkin aggressive lymphomas. Although it is morphologically characterized, immunophenotypic and cytogenetic diagnosis remains complex. In 2008, the WHO has introduced a new diagnostic class of aggressive B-cell lymphomas with features intermediate between BL and DLBCL. This diagnostic class represents a temporary container of aggressive B-cell lymphomas, not completely belonging to the BL and DLBCL categories. The importance of establishing a correct diagnosis would allow a better prognostic classification and a better therapeutic approach. In this review, we summarize the main diagnostic approaches necessary for appropriate diagnoses and we emphasize the importance of cytogenetic analysis of the oncogene Myc in the histopathological diagnosis and the prognostic/predictive stratification. In this contest, Myc represents the more involved gene in the development of these lymphomas. Therefore, we analyze the genetic aberrations causing its over-expression and the concomitant deregulation of molecular pathways related to it. We also propose a FISH approach useful in the diagnosis of these lymphomas.

KW - Aggressive non-Hodgkin B-cell lymphoma

KW - B-cell lymphoma unclassifiable

KW - Burkitt Lymphoma

KW - Diffuse large B cell lymphoma

KW - FISH

KW - MYC

UR - http://www.scopus.com/inward/record.url?scp=84884686726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884686726&partnerID=8YFLogxK

U2 - 10.1186/1750-9378-8-37

DO - 10.1186/1750-9378-8-37

M3 - Article

C2 - 24079473

AN - SCOPUS:84884686726

VL - 8

JO - Infectious Agents and Cancer

JF - Infectious Agents and Cancer

SN - 1750-9378

IS - 1

M1 - 37

ER -